The renewal period for AACR membership is now open. Members are encouraged to renew their membership today to maintain access to AACR benefits in 2027.
brnw.ch/21x6LBS
Submit an abstract by December 7 for the AACR IO Conference on Discovery and Innovation in Cancer Immunology (February 28-March 3, 2027; Los Angeles), chaired by Nina Bhardwaj, Elizabeth M. Jaffee, and Antoni Ribas. Learn more:
brnw.ch/21x6LxK
#AACRIO27
The AACR-Lustgarten Foundation Career Development Awards for Pancreatic Cancer Research, in Honor of Ruth Bader Ginsburg and John Robert Lewis, are 3-year, $300,000 grants to support new ideas that advance pancreatic cancer research. Apply by Nov 20:
brnw.ch/21x6Loy
Submissions are open for the 2027 AACR June L. Biedler Prize for Cancer Journalism. This $5,000 prize honors journalists for coverage that enhances the public’s understanding of cancer. Learn more: brnw.ch/21x6Lk9
The Bosarge Family Foundation-Waun Ki Hong Scholar Award for Regenerative Cancer Medicine provides $120,000 over 2 years to support fellows conducting research to enhance the physiology of cancer survivors through regenerative medicine. Apply by Nov 18:
brnw.ch/21x6LcI
The AACR-Kids Beating Cancer Margaret Guedes Monosomy 7 Legacy Cancer Research Grant is a 3-year, $300,000 grant to support independent investigators conducting research on monosomy 7 AML and/or other high-risk cytogenetic AML subtypes. Apply by Dec 1:
brnw.ch/21x6JWn
Submit an abstract by October 29 for the AACR Special Conference on Redefining Lung Cancer (January 14-17; San Diego), held in association with the AACR Lung Cancer Task Force and chaired by Charles Swanton. Learn more:
brnw.ch/21x6JTU
#AACRlung27 @CharlesSwanton
#AACRonCampus in Bogotá, Colombia, adjourned Tuesday. AACR leaders Jennifer Guerriero, Laura Fejerman, Brian Rivers, and Francisco Sanchez Vega discussed topics such as Personalizing Immunotherapy, Genomics, and Using AI to Advance Cancer Equity with early-career researchers.
A first-of-its-kind cancer vaccine demonstrated success in reducing the risk of recurrence for patients with high-risk melanoma. Learn more about the therapy and phase III trial results on the #AACRBlog: brnw.ch/21x6JLr
#AACR26 session recordings are available to meeting registrants for on-demand viewing through Saturday, October 31. Learn more:
brnw.ch/21x6JKw
